These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biological evaluation of bisbenzaldehydes against four Mycobacterium species. Cappoen D; Forge D; Vercammen F; Mathys V; Kiass M; Roupie V; Anthonissen R; Verschaeve L; Vanden Eynde JJ; Huygen K Eur J Med Chem; 2013 May; 63():731-8. PubMed ID: 23567963 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro investigation of halogenated 1,3-bis(4-nitrophenyl)triazenide salts as antitubercular compounds. Torfs E; Vajs J; de Macedo MB; Cools F; Vanhoutte B; Gorbanev Y; Bogaerts A; Verschaeve L; Caljon G; Maes L; Delputte P; Cos P; Košmrlj J; Cappoen D Chem Biol Drug Des; 2018 Feb; 91(2):631-640. PubMed ID: 28845550 [TBL] [Abstract][Full Text] [Related]
4. 2,4-Dialkyl-8,9,10,11-tetrahydrobenzo[g]pyrimido[4,5-c]isoquinoline-1,3,7,12(2H,4H)-tetraones as new leads against Mycobacterium tuberculosis. Claes P; Cappoen D; Uythethofken C; Jacobs J; Mertens B; Mathys V; Verschaeve L; Huygen K; De Kimpe N Eur J Med Chem; 2014 Apr; 77():409-21. PubMed ID: 24681334 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors. Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188 [TBL] [Abstract][Full Text] [Related]
6. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs. Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones. de Macedo MB; Kimmel R; Urankar D; Gazvoda M; Peixoto A; Cools F; Torfs E; Verschaeve L; Lima ES; Lyčka A; Milićević D; Klásek A; Cos P; Kafka S; Košmrlj J; Cappoen D Eur J Med Chem; 2017 Sep; 138():491-500. PubMed ID: 28689097 [TBL] [Abstract][Full Text] [Related]
8. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity. Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154 [TBL] [Abstract][Full Text] [Related]
9. 1,2,3,4,8,9,10,11-octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis. Cappoen D; Claes P; Jacobs J; Anthonissen R; Mathys V; Verschaeve L; Huygen K; De Kimpe N J Med Chem; 2014 Apr; 57(7):2895-907. PubMed ID: 24611928 [TBL] [Abstract][Full Text] [Related]
11. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines. Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides. Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514 [TBL] [Abstract][Full Text] [Related]
13. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies. Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues. Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221 [TBL] [Abstract][Full Text] [Related]
15. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry. Akselband Y; Cabral C; Shapiro DS; McGrath P J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore. Salunke SB; Azad AK; Kapuriya NP; Balada-Llasat JM; Pancholi P; Schlesinger LS; Chen CS Bioorg Med Chem; 2015 May; 23(9):1935-43. PubMed ID: 25818768 [TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors. Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902 [TBL] [Abstract][Full Text] [Related]
18. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity. Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897 [TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique. Luo X; Pires D; Aínsa JA; Gracia B; Mulhovo S; Duarte A; Anes E; Ferreira MJ J Ethnopharmacol; 2011 Sep; 137(1):114-20. PubMed ID: 21571059 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H(37)Rv, MDR and NRP Mycobacterium tuberculosis. Figueiredo R; Moiteiro C; Medeiros MA; da Silva PA; Ramos D; Spies F; Ribeiro MO; Lourenço MC; Júnior IN; Gaspar MM; Cruz ME; Curto MJ; Franzblau SG; Orozco H; Aguilar D; Hernandez-Pando R; Costa MC Bioorg Med Chem; 2009 Jan; 17(2):503-11. PubMed ID: 19119013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]